Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion
Open Access
- 25 April 2012
- journal article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 76
Abstract
Cerebral ischemia is associated with the activation of glial cells, infiltration of leukocytes and an increase in inflammatory mediators in the ischemic brain and systemic circulation. How this inflammatory response influences lesion size and neurological outcome remains unclear. D-JNKI1, an inhibitor of the c-Jun N-terminal kinase pathway, is strongly neuroprotective in animal models of stroke. Intriguingly, the protection mediated by D-JNKI1 is high even with intravenous administration at very low doses with undetectable drug levels in the brain, pointing to a systemic mode of action, perhaps on inflammation.Keywords
This publication has 25 references indexed in Scilit:
- Experimental Stroke-Induced Changes in the Bone Marrow Reveal Complex Regulation of Leukocyte ResponsesJournal of Cerebral Blood Flow & Metabolism, 2010
- A Rapid and Transient Peripheral Inflammatory Response Precedes Brain Inflammation after Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2009
- Ambivalent Aspects of Interleukin-6 in Cerebral Ischemia: Inflammatory versus Neurotrophic AspectsJournal of Cerebral Blood Flow & Metabolism, 2008
- Inflammation and ischaemic strokeCurrent Opinion in Neurology, 2007
- Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal KinasesMicrobiology and Molecular Biology Reviews, 2006
- c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microgliaGlia, 2005
- Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcomeBMC Neurology, 2004
- An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosisJournal of Neuroimmunology, 2003
- Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and InflammationPhysiological Reviews, 2001
- Cell-Permeable Peptide Inhibitors of JNKDiabetes, 2001